אוקסי-וט תרסיס וטרינרי
m.p.vet ltd - oxytetracycline hydrochloride 3.5 % - spray - oxyvet spray is indicated for topical infections sensitive to oxytetracycline in horses, cattle, sheep, goats, pigs, dogs, cats.
אוקסי-וט תרסיס וטרינרי
m.p.vet ltd - oxytetracycline hydrochloride - ספריי - oxytetracycline hydrochloride 1.4 %w/v
קורפורל - ג'ל רחצה - la provence
א.ל. ארמן יצור תמרוקים בעמ - רחצת הגוף
silicone implants& accessories -all models approved by the fda ,canadian health canada,australian tga and or carrying a valid ce
נובוגולד בע"מ - רופא - משתלי סיליקון ונילווים
angiographic catheters, hemodialysis micro access set and drainage catheters approved by the fda
עינת מדיקל סוכנויות בע"מ - אחר
easystand standing frames
אי. טי. שיקום בע"מ - אחר - improve circulation/respiratory/ cardio function
קונבניה וטרינרי
zoetis israel holding b.v., israel - cefovicin as sodium salt - אבקה וממס להכנת תמיסה להזרקה - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.
אורופאק 200 ג' וטרינרי
zoetis israel holding b.v., israel - chlortetracycline as dsafp biomass - גרנולות - chlortetracycline as dsafp biomass 20 %w/w
אורופאק 200 ג' וטרינרי
zoetis israel holding b.v., israel - chlortetracycline as dsafp biomass - גרנולות - chlortetracycline as dsafp biomass 20 %w/w
פלומיסט קואדריוואלנט
astrazeneca (israel) ltd - a/darwin/9/2021 (h3n2)-like virus; a/victoria/4897/2022 (h1n1)pdm09-like virus; b/austria/1359417/2021 (b/victoria lineage)-like virus; b/phuket/3073/2013 (b/yamagata lineage)-like virus - ספריי לאף - b/phuket/3073/2013 (b/yamagata lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/darwin/9/2021 (h3n2)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; b/austria/1359417/2021 (b/victoria lineage)-like virus 7 ±0.5 log10 ffu^a / 0.2 ml; a/victoria/4897/2022 (h1n1)pdm09-like virus 7 ±0.5 log10 ffu^a / 0.2 ml - influenza, inactivated, split virus or surface antigen - influenza, purified antigen - flumist quadrivalent is a vaccine indicated for active immunization for the prevention of influenza disease caused by influenza a subtype viruses ad type b viruses contained in the vaccine. flumist quadrivalent is approved for use in persons 2 through 49 years of age.